Rampart Bioscience Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Employees
-
30
- Latest Deal Type
-
Out of Business
Rampart Bioscience General Information
Description
Developer of gene medicines intended to provide guarded, long-lasting treatments for various diseases. The company's platform offers proprietary development and delivery platforms, which together create optimized therapeutics in a revocable, non-viral format, thereby assisting patients with genetically driven diseases by integrating capabilities from various key scientific disciplines including gene delivery, protein sciences, and clinical translation.
Contact Information
Website
www.rampartbio.comCorporate Office
- 233 West Chestnut Avenue
- Suite 240
- Phoenix, AZ 85013
- United States
Corporate Office
- 233 West Chestnut Avenue
- Suite 240
- Phoenix, AZ 85013
- United States
Rampart Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 09-Jan-2026 | Completed | Out of Business | |||
| 2. Early Stage VC (Series A) | 11-Sep-2023 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Jan-2022 | $40M | $40M | Completed | Generating Revenue |
Rampart Bioscience Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Seed-2 | 36,044,609 | $0.001000 | $0.91 | $0.91 | 1x | $0.91 | 27.35% | |
| Seed | 12,440,000 | $0.001000 | $1 | $1 | 1x | $1 | 9.44% |
Rampart Bioscience Comparisons
Industry
Financing
Details
Rampart Bioscience Competitors (111)
One of Rampart Bioscience’s 111 competitors is StemiRNA Therapeutics, a Venture Capital-Backed company based in Shanghai, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| StemiRNA Therapeutics | Venture Capital-Backed | Shanghai, China | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Genevant | Corporate Backed or Acquired | Vancouver, Canada | ||||
| CRISPR Therapeutics | Formerly VC-backed | Zug, Switzerland |
Rampart Bioscience Patents
Rampart Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026089719-A1 | Dna vectors having specialized secondary structures for use in treating hypophosphatasia | Pending | 24-Oct-2024 | ||
| WO-2026090562-A1 | Dna vectors having specialized secondary structures for use in treating hypophosphatasia | Pending | 24-Oct-2024 | ||
| WO-2025090786-A1 | Reduced immunogenic gene therapy protocols using circular, extended cruciform containing non-viral vectors | Inactive | 24-Oct-2023 | ||
| WO-2025090786-A9 | Reduced immunogenic gene therapy protocols using circular, extended cruciform containing non-viral vectors | Inactive | 24-Oct-2023 | ||
| AU-2023308977-A1 | Non-immunogenic circular, non-viral dna vectors | Pending | 19-Jul-2022 | C12N15/85 |
Rampart Bioscience Signals
Rampart Bioscience FAQs
-
When was Rampart Bioscience founded?
Rampart Bioscience was founded in 2019.
-
Where is Rampart Bioscience headquartered?
Rampart Bioscience is headquartered in Phoenix, AZ.
-
What is the size of Rampart Bioscience?
Rampart Bioscience has 30 total employees.
-
What industry is Rampart Bioscience in?
Rampart Bioscience’s primary industry is Drug Discovery.
-
Is Rampart Bioscience a private or public company?
Rampart Bioscience is a Private company.
-
What is Rampart Bioscience’s current revenue?
The current revenue for Rampart Bioscience is .
-
How much funding has Rampart Bioscience raised over time?
Rampart Bioscience has raised $125M.
-
Who are Rampart Bioscience’s competitors?
StemiRNA Therapeutics, etherna, Editas Medicine, Genevant, and CRISPR Therapeutics are some of the 111 competitors of Rampart Bioscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process